Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Twelve outstanding articles have been shortlisted for this year’s Max Perutz Science Writing Award, including articles from three Medical Sciences DPhil students.

The Max Perutz Award, the MRC's annual writing competition, asks MRC-funded PhD students to write up to 800 words about their research and why it matters, in a way that would interest a non-scientific audience.

Congratulations to the three Medical Sciences DPhil students who have been shortlisted:

  • Magda Mareckova, Nuffield Department of Women's & Reproductive Health:“One in ten women suffers from endometriosis - can studying the endometrium cell by cell help us diagnose it?” Read more
  • Akira Wiberg, Nuffield Department of Orthopaedic, Rheumatology & Musculoskeletal Sciences: “Getting on your nerves” 
  • Amy Southern, Department of Biochemistry/MRC Harwell: “Making sense of a sticky situation: finding the 'glue ear gene' in Down syndrome". Read more

The winner, who will receive a £1,500 prize, will be announced at the awards ceremony on 15 October at the Royal Institution, London. All shortlisted articles will be published on the MRC website on 16 October.

Read more (MRC website)

Similar stories

Oxford vaccine creator Professor Sarah Gilbert awarded RSA Albert Medal

Awards and Appointments Coronavirus COVID-19 General Innovation Research

Professor Sarah Gilbert has been awarded the Royal Society for Arts, Manufactures and Commerce’ (RSA) Albert Medal for her work on the Oxford vaccine.

PRINCIPLE Covid-19 treatments trial widens to under 50s and adds colchicine

Clinical Trials Coronavirus COVID-19 General Research

From today, the UK’s national priority platform trial of Covid-19 treatments for recovery at home launches its investigation of the gout drug colchicine, and expands for the first time to include adults of any age.

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

Coronavirus COVID-19 General Research

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.